查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1994141

牛健康市场：2026-2032年全球市场预测（依产品类型、牛种、给药途径、疾病区域及最终用户划分）

Cattle Health Market by Product Type, Cattle Type, Mode Of Administration, Disease Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，牛健康市场价值将达到 83.3 亿美元，到 2026 年将成长到 88.2 亿美元，到 2032 年将达到 123.2 亿美元，复合年增长率为 5.75%。

主要市场统计数据
基准年 2025 83.3亿美元
预计年份：2026年 88.2亿美元
预测年份：2032年 123.2亿美元
复合年增长率 (%) 5.75%

简要概述了现代动物管理中重新定义牛健康优先事项、临床实践和农场层面决策的因素。

牛健康领域正处于科学进步、监管环境演变和畜牧业经济转型交汇的十字路口，迫使生产者和服务提供者重新定义其在动物福利、生产力和生物安全方面的优先事项。在此背景下，价值链上的相关人员必须平衡对改善疾病预防和诊断技术的需求，以及日益重视的实际限制因素，例如劳动力供应、供应链韧性和合理使用抗生素。本导言概述了后续分析的框架，旨在识别影响产品需求、分销管道和农场决策的因素。

诊断技术的创新、合理使用抗生素、不断发展的分销管道以及精准控制如何重塑产品选择、临床管道和农场韧性？

在科学进步、监管重新评估和相关人员期望转变的推动下，牛的健康格局正在经历多项变革。诊断技术的快速发展，包括检查室检测和携带式快速检测套组，使得细菌性、病毒性和寄生虫性疾病的早期检测成为可能，从而支持更有针对性的治疗和预防干预措施。同时，对合理使用抗生素的持续重视正在加速替代治疗方法和预防措施的推广，并推动饲料添加剂组合药物的发展，这些配方提供酵素、益生元、益生菌、维生素和矿物质，以支持免疫功能和代谢稳定性。

近期关税措施对与牛健康相关的整个价值链的采购、供应连续性和筹资策略的营运和策略影响。

美国近期推出的关税措施为依赖进口的牛保健供应链环节带来了新的挑战，导致成本结构和筹资策略发生变化。依赖跨境采购药品活性成分、诊断试剂、专用疫苗成分和特定饲料添加剂的製造商和经销商被迫重新评估与供应商的关係，实现货源多元化，并在某些情况下加快本地化生产，以维持供应的连续性和稳定的利润率。这些因应措施促使企业重新关注供应链图谱、供应商合格和库存策略，以减轻关税衝击的影响。

这项研究揭示了产品、分销管道、牛类、疾病、给药途径和应用细分如何影响购买行为和创新重点。

细分市场分析揭示了影响购买行为和产品开发重点的微妙需求因素，这些因素涵盖产品类型、分销管道、牛类类别、疾病分类、给药途径和应用领域。在产品类型内部，诊断产品呈现两极化的趋势：检查室检测支援确诊和监测方案，而快速检测套组则支援农场和诊所的照护现场决策。消毒剂和杀菌剂在生物安全通讯协定严格的地区受到优先考虑，而饲料添加剂，包括酵素、益生元、益生菌、维生素和矿物质，则有助于全面提高消化效率和免疫功能。

了解影响产品采用和供应链设计的区域性法规结构、生产系统和分销趋势的差异。

区域趋势对牛健康管理的法规结构、疾病流行情况、生产系统和商业策略有显着影响。在美洲，一体化的商业运营、先进的兽医基础设施以及不断变化的消费者期望，推动了对高效疫苗、精准诊断以及优先考虑合理使用的药品和饲料添加剂的需求，促使供应商将可追溯性和性能数据作为差异化优势。在欧洲、中东和非洲，监管的多样性和生产规模的差异导致产品采用模式的分化。有些市场优先考虑高科技诊断和严格的抗​​生素监管，而有些市场则需要经济高效的配方和完善的低温运输物流来应对地方性疾病的压力。

竞争格局洞察凸显了综合产品供应、证据产生和经销伙伴关係如何定义牛健康市场的领导地位。

牛健康领域的竞争格局呈现出多元化的特征，既有跨国製药公司，也有专业动物用药品公司、诊断技术创新企业和新兴饲料添加剂专家。主要企业透过整合疫苗、标靶药物、诊断技术和技术服务等产品，提供满足生产者复杂需求的端到端牛健康解决方案，脱颖而出。同时，小规模、更灵活的公司则倾向于专注于细分市场，例如快速照护现场诊断、新型益生菌配方或针对特定区域病原体的在地化疫苗平台。

为製造商和经销商制定切实可行的策略措施，以增强其韧性，加快部署速度，并改善集团层面的健康结果。

行业领导企业应优先采取一系列措施，以最大限度地利用需求变化带来的益处，同时降低业务风险。首先，投资诊断能力建设，以支持农场层面的快速决策，并将诊断结果转化为具体的治疗和预防通讯协定。其次，加速采购和生产多元化，以减轻贸易中断的影响，同时加强供应商选择标准和库存策略，以确保供应的连续性。

我们采用透明的混合方法研究途径，结合相关人员访谈、监管审查和比较分析，为牛的健康提供可操作的见解。

本分析整合了从与行业相关人员的访谈中获得的定性和定量资讯、对二手文献的回顾以及对监管和贸易趋势的比较评估，以确保对牛健康动态形成全面而平衡的观点。主要研究包括与兽医、产品经理、分销主管和农场经营者进行结构化访谈，以收集有关诊断使用模式、治疗偏好和采购行为的实地见解。这些直接观察结果与官方监管文件、疾病管理和药理学方面的科学文献以及检验的企业资讯披露进行了交叉比对，以提高准确性。

为了推动牛健康管理的可持续改进，我们正在整合策略挑战，并专注于诊断、管理和供应链韧性。

总之，牛健康管理领域目前正经历着建设性的转型期，诊断技术的进步、管理要求的提高以及分销管道的创新正在重塑商业性和临床规范。那些能够将产品开发、供应链韧性以及与兽医和养殖户开展循证合作相结合的企业，将更有利于推动技术应用并改善动物福利。区域差异和关税相关的供应考虑凸显了製定本地化策略和柔软性采购对于维持业务连续性和竞争力的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：牛保健市场：依产品类型划分

  • 製药
    • 抗生素
    • 抗发炎药和止痛药
    • 荷尔蒙和生殖疗法
    • 胃肠道治疗
    • 呼吸治疗
  • 疫苗
    • 减毒活病毒疫苗
    • 灭活疫苗
    • 类毒素疫苗
    • 重组疫苗和次单位疫苗
    • 联合疫苗
  • 杀虫剂
    • 体外寄生虫控製剂
    • 体内寄生虫控製剂
    • 体内外寄生虫控製剂
  • 诊断
    • 农场快速检测
    • 实验室检测
    • 进阶影像诊断
    • 数位监控工具
  • 营养产品
    • 矿物质补充剂
    • 维生素补充剂
    • 益生菌和益生元
    • 电解质和补水产品
    • 特殊治疗饲料
  • 饲料添加剂
    • 提高生产效率的添加剂
    • 霉菌毒素吸附剂
    • 酵素添加剂
    • 酸味剂和缓衝剂
  • 监测设备和穿戴式装置
    • 衣领和颈标
    • 耳标植入
    • 反刍和摄食感测器
    • 活动和运动感测器
    • 健康事件警报系统
  • 农场管理软体服务
    • 健康记录管理
    • 决策支援/分析
    • 远端医疗和远距监测平台
    • 整合资讯服务

第九章：牛健康市场：以牛的类型划分

  • 牛
  • 牛
  • 双用途牛
  • 牛
  • 种牛和种牛

第十章：牛健康市场：依给药途径划分

  • 口服
    • Bolus/片剂
    • 口服
    • 糊状凝胶
    • 药用饲料
  • 注射药物
    • 皮下注射
    • 肌肉内注射
    • 静脉注射
  • 外用
    • 毛孔细緻滴剂
    • 喷涂浸渍
    • 药膏和乳霜
  • 在乳房
    • 泌乳牛的乳房内给药
    • 干乳牛的子宫内给药
  • 鼻内
  • 嵌入式
    • 生长激素植入
    • 长效药物植入
  • 饲料添加剂型
  • 水溶性

第十一章牛健康市场：依疾病区域划分

  • 感染疾病
    • 细菌感染疾病
    • 病毒感染疾病
    • 霉菌感染疾病
    • 混合感染疾病和性行为感染
  • 寄生虫病
    • 体内寄生虫
    • 体外寄生虫
    • 原虫性疾病
  • 乳腺炎和乳房健康
  • 呼吸系统疾病
    • 上呼吸道疾病
    • 下呼吸道疾病
    • 复杂呼吸症候群
  • 消化系统疾病
    • 腹泻疾病
    • 腹泻和酸中毒
  • 代谢和营养紊乱
    • 能量代谢紊乱
    • 矿物质失衡
    • 维生素缺乏
    • 管腔功能障碍
  • 生殖和产科疾病
    • 育种管理问题
    • 分娩前、分娩中、分娩后的疾病
    • 性行为感染传染病
  • 跛行和肌肉骨骼疾病
    • 蹄甲疾病
    • 关节和肢体疾病
    • 创伤/损伤

第十二章牛健康市场：依最终用户划分

  • 大型商业农场
  • 中小农场
  • 兽医医院和诊所
  • 移动式和现场兽医服务
  • 畜牧合作社和生产者组织
  • 政府和学术机构
  • 动物健康服务提供者
    • 育种管理服务供应商
    • 牛健康咨询公司
    • 外部联络及咨询服务

第十三章牛健康市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章牛健康市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章牛健康市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国牛健康市场

第十七章：中国牛健康市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Biomin GmbH
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma AD
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Ltd.
  • Jurox Pty Ltd.
  • Kemin Industries, Inc.
  • Laboratorios Hipra, SA
  • Meiji Seika Pharma Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Ouro Fino Saude Animal Ltda.
  • Phibro Animal Health Corporation
  • PhytobIoTics Futterzusatzstoffe GmbH
  • Vaxxinova International BV
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
  • Zydus Animal Health and Investments Limited
Product Code: MRR-1A1A064C0406

The Cattle Health Market was valued at USD 8.33 billion in 2025 and is projected to grow to USD 8.82 billion in 2026, with a CAGR of 5.75%, reaching USD 12.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.33 billion
Estimated Year [2026] USD 8.82 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 5.75%

A concise contextual overview of the forces redefining cattle health priorities, clinical practice, and farm-level decision-making in modern animal management

The cattle health landscape is at a crossroads where scientific progress, regulatory evolution, and shifting farm economics are converging to redefine how producers and service providers prioritize animal welfare, productivity, and biosecurity. In this context, stakeholders across the value chain must reconcile the push for improved disease prevention and diagnostics with practical constraints such as labor availability, supply chain resilience, and rising emphasis on antimicrobial stewardship. This introduction frames the subsequent analysis by clarifying the forces shaping product demand, influencing distribution choices, and altering farm-level decision-making.

This report centers on the tangible intersections between innovation and implementation: how laboratory and point-of-care diagnostics are altering clinical workflows; how feed additives and targeted pharmaceuticals are being integrated into herd health plans; and how vaccines, both established and emerging, are being deployed to mitigate infectious and parasitic challenges. By establishing this baseline, readers will gain a clear understanding of why certain intervention categories are gaining prominence and how institutional and farm-level priorities are adapting in response to animal health imperatives and market pressures.

Throughout the ensuing sections, we connect strategic implications to operational realities, helping executives, product managers, and veterinarians align R&D, commercial planning, and on-the-ground practices to improve cattle health outcomes while managing cost and compliance considerations.

How diagnostic innovation, antimicrobial stewardship, distribution evolution, and precision management are reshaping product selection, clinical pathways, and farm resilience

The landscape of cattle health is experiencing several transformative shifts driven by scientific advances, regulatory recalibration, and changing stakeholder expectations. Rapid improvements in diagnostics technology, including laboratory testing and portable rapid test kits, are enabling earlier detection of bacterial, viral, and parasitic conditions, which in turn supports more targeted therapeutic and preventive interventions. Simultaneously, continued emphasis on antimicrobial stewardship is accelerating adoption of alternative therapeutics and preventive measures, incentivizing growth in feed additive formulations that deliver enzymes, prebiotics, probiotics, vitamins, and minerals to support immunity and metabolic stability.

Distribution models are evolving as well, with online channels complementing traditional farm supply outlets, pharmacies, and veterinary hospitals to improve accessibility and traceability of products. Regulatory scrutiny around hormones and growth promoters, coupled with heightened consumer interest in sustainable and welfare-oriented production, is prompting manufacturers to diversify portfolios toward vaccines and non-antibiotic therapeutic options. In parallel, data-driven herd management and precision livestock farming techniques are informing product selection and administration routes, with injectable, oral, topical, and inhalation options being deployed in more strategic and condition-specific ways.

Taken together, these shifts signal a move from broad, reactive interventions toward integrated, preventive, and data-informed strategies that prioritize herd resilience, product safety, and long-term viability for producers and value chain partners.

Operational and strategic consequences of recent tariff measures on sourcing, supply continuity, and procurement strategies across the cattle health value chain

Recent tariff actions in the United States introduced new considerations for import-dependent segments of the cattle health supply chain, altering cost structures and procurement strategies. Manufacturers and distributors that rely on cross-border sourcing for active pharmaceutical ingredients, diagnostic reagents, specialized vaccine components, and certain feed additive raw materials have had to reassess supplier relationships, diversify sourcing footprints, and, in some instances, accelerate localization of production to maintain supply continuity and margin stability. These operational responses have translated into renewed emphasis on supply chain mapping, vendor qualification, and inventory strategies to reduce exposure to tariff-driven disruptions.

At the same time, regulatory agencies and trade partners are adapting to the changed trade environment through procedural clarifications and bilateral dialogues intended to minimize unintended consequences for animal health inputs. The net effect for industry participants is a heightened need for commercial agility: procurement teams are pursuing multi-sourcing and strategic stockholding while product managers are evaluating reformulation opportunities that reduce reliance on tariff-sensitive inputs. Veterinary service providers and farm operators are also adjusting purchasing cadence and product selection, preferring accessible distribution channels that mitigate delivery risks.

In short, tariffs have reinforced the strategic importance of resilient value chains, compelling companies across the cattle health ecosystem to invest in sourcing flexibility, supplier partnerships, and near-term operational contingency planning to safeguard animal care and business continuity.

Clarifying how product, channel, cattle category, disease, administration route, and application segmentation combine to direct purchasing behavior and innovation priorities

Segmentation analysis reveals nuanced demand drivers across product types, distribution channels, cattle categories, disease classes, administration routes, and applications, each shaping purchasing behavior and product development priorities. Within product categories, diagnostics present a bifurcated landscape where laboratory testing supports confirmatory and surveillance programs while rapid test kits enable point-of-care decision-making on farms and in clinics. Disinfectants and sanitizers are prioritized where biosecurity protocols are stringent, and feed additives span enzymes, prebiotics and probiotics, plus vitamins and minerals that collectively address digestive efficiency and immune competence.

Pharmaceutical portfolios require careful segmentation: anthelmintics remain essential for parasite control, anti-inflammatories address acute clinical needs, antibiotics are increasingly subject to stewardship constraints, and hormones and growth promoters face regulatory and market scrutiny that influence adoption. Vaccines span bacterial, parasitic, and viral targets and are central to preventive herd health strategies. Distribution patterns show that farm supplies outlets continue to be primary procurement points for routine products, while online channels are expanding accessibility and transactional efficiency; pharmacies and veterinary hospitals and clinics play critical roles for prescription and professionally administered interventions.

Cattle types-beef, calves, and dairy-exhibit distinct health management priorities linked to production cycles, nutrition, and disease susceptibility, driving divergent demand for formulation types and administration routes. Disease-type segmentation underscores the breadth of clinical focus areas, from bacterial and viral infections to parasitic and metabolic disorders and reproductive and respiratory conditions, each requiring tailored diagnostic, preventive, and therapeutic approaches. Administration routes-injectable, oral, topical, and inhalation-must align with product pharmacokinetics, ease of use on farm, and welfare considerations. Finally, applications ranging from growth promotion and nutritional supplementation to preventive, reproductive management, and therapeutic uses determine how products are positioned commercially and integrated into herd health programs.

Understanding regional variation in regulatory frameworks, production systems, and distribution dynamics that shape product adoption and supply chain design

Regional dynamics exert a strong influence on regulatory frameworks, disease prevalence, production systems, and commercial strategies in cattle health. In the Americas, integrated commercial operations, advanced veterinary infrastructure, and evolving consumer expectations drive demand for high-efficacy vaccines, precision diagnostics, and stewardship-aligned pharmaceuticals and feed additives, prompting suppliers to emphasize traceability and performance data as differentiators. Across Europe, the Middle East and Africa, regulatory diversity and varied production scales mean that product adoption patterns diverge: some markets prioritize high-tech diagnostics and stringent antibiotic regulations, while others require cost-sensitive formulations and robust cold-chain logistics to manage endemic disease pressures.

Asia-Pacific presents distinct dynamics with rapid modernization of dairy and beef systems, heterogeneous disease burdens, and expanding distribution ecosystems where online channels and veterinary clinics are increasingly influential. Regional procurement and supply chain approaches reflect these conditions: manufacturers adapt packaging, formulations, and support services for diverse cold-chain capabilities, veterinary capacity, and farm management practices. Moreover, public and private sector disease control programs and regional trade policies shape vaccine deployment strategies and prioritize interventions that address prevalent bacterial, viral, and parasitic challenges.

Understanding these regional nuances enables companies to align product development, registration strategies, and commercial engagement to the specific needs of producers, veterinarians, and regulators in each geography, thereby improving adoption and impact.

Competitive landscape insights highlighting how integrated product offerings, evidence generation, and distribution partnerships define leadership in cattle health markets

Competitive dynamics in the cattle health space reflect a mix of multinational pharmaceutical firms, specialized animal health companies, diagnostic innovators, and emerging feed additive specialists. Leading players differentiate through integrated offerings that combine vaccines, targeted pharmaceuticals, diagnostics, and technical services, enabling end-to-end herd health solutions that resonate with progressive producers. Meanwhile, smaller, agile firms often focus on niche opportunities such as rapid point-of-care diagnostics, novel probiotic blends, or localized vaccine platforms that address region-specific pathogens.

Collaboration between manufacturers and veterinary services is a growing strategic priority, with companies investing in field trials, real-world evidence generation, and educational programs to demonstrate product value and encourage protocol adoption. Strategic partnerships with distribution networks, including online platforms and veterinary hospitals, are expanding reach and streamlining procurement, while investments in cold-chain logistics and regulatory affairs capabilities help accelerate market entry and maintain product integrity. Additionally, companies are increasingly transparent about stewardship commitments and data transparency, which strengthens trust with veterinarians, producers, and regulators.

Going forward, competitive advantage will accrue to organizations that combine technical innovation with robust supply chain safeguards, evidence-based engagement, and services that lower adoption friction for farm operators and clinical practitioners.

Practical, high-impact strategic moves for manufacturers and distributors to strengthen resilience, accelerate adoption, and improve herd-level health outcomes

Industry leaders should pursue a set of prioritized actions to capitalize on evolving demand while reducing operational risk. First, invest in diagnostic capabilities that support rapid, on-farm decision-making and link diagnostic outputs to actionable treatment and prevention protocols. Second, accelerate diversification of sourcing and production to reduce exposure to trade-related disruptions, while strengthening supplier qualification and inventory strategies to maintain continuity of supply.

Third, reframe product portfolios to emphasize antimicrobial stewardship and non-antibiotic interventions, pairing therapeutics with vaccination strategies and targeted feed additives that support immune resilience and metabolic health. Fourth, deepen engagement with distribution partners across farm supply outlets, online channels, pharmacies, and veterinary hospitals to enhance accessibility and ensure appropriate product use. Fifth, tailor regional go-to-market approaches that reflect the distinct regulatory, logistical, and disease prevalence conditions in the Americas, Europe Middle East & Africa, and Asia-Pacific, and invest in localized trials and educational outreach to support adoption.

Finally, augment competitive positioning by generating robust field data, leveraging digital tools for herd-level insights, and offering service-oriented solutions that simplify adoption. Taken together, these steps will enable companies to deliver higher value, mitigate operational risk, and align product strategy with the practical needs of veterinarians and producers.

Transparent mixed-methods research approach combining stakeholder interviews, regulatory review, and comparative analysis to support actionable cattle health insights

This analysis synthesizes qualitative and quantitative inputs drawn from primary interviews with industry stakeholders, secondary literature review, and comparative assessment of regulatory and trade developments to ensure a comprehensive and balanced perspective on cattle health dynamics. Primary research included structured conversations with veterinary practitioners, product managers, distribution executives, and farm operators to capture on-the-ground insights into diagnostic use patterns, treatment preferences, and procurement behaviors. These firsthand observations were triangulated with public regulatory documentation, scientific literature on disease management and pharmacology, and validated company disclosures to enhance accuracy.

The methodology emphasizes transparency and replicability: sources were documented, thematic coding was applied to interview data, and cross-validation checks were conducted to reconcile divergent viewpoints. Where appropriate, scenario analysis was used to assess operational responses to trade and supply chain disruptions, while technology and adoption trends were evaluated through product pipeline reviews and stakeholder readiness assessments. This mixed-methods approach ensures the findings reflect both technical realities and commercial practicalities relevant to decision-makers across the cattle health ecosystem.

Synthesis of strategic imperatives emphasizing diagnostics, stewardship, and supply chain resilience to guide sustainable improvements in cattle health management

In conclusion, the cattle health sector is navigating a period of constructive disruption where diagnostic advances, stewardship imperatives, and distribution innovations are reshaping commercial and clinical norms. Companies that align product development, supply chain resilience, and evidence-based engagement with veterinarians and producers will be better positioned to influence adoption and improve animal welfare outcomes. Regional heterogeneity and tariff-induced supply considerations underscore the importance of tailored strategies and sourcing flexibility to maintain continuity and competitiveness.

The practical implications for stakeholders are clear: prioritize diagnostics and preventive measures that reduce reliance on broad-spectrum therapeutics, invest in formulation and logistics that suit local production systems, and cultivate partnerships that bring clinical credibility and distribution efficiency. By translating these insights into coordinated action-spanning R&D prioritization, supplier diversification, and targeted market engagement-industry participants can address immediate operational challenges while building sustainable pathways for long-term improvement in cattle health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cattle Health Market, by Product Type

  • 8.1. Pharmaceuticals
    • 8.1.1. Antibiotics
    • 8.1.2. Anti-inflammatory & Analgesics
    • 8.1.3. Hormones & Reproductive Therapies
    • 8.1.4. Gastrointestinal Therapies
    • 8.1.5. Respiratory Therapies
  • 8.2. Vaccines
    • 8.2.1. Live Attenuated Vaccines
    • 8.2.2. Inactivated Vaccines
    • 8.2.3. Toxoid Vaccines
    • 8.2.4. Recombinant & Subunit Vaccines
    • 8.2.5. Combination Vaccines
  • 8.3. Parasiticides
    • 8.3.1. Ectoparasiticides
    • 8.3.2. Endoparasiticides
    • 8.3.3. Endectocides
  • 8.4. Diagnostics
    • 8.4.1. Rapid On-farm Tests
    • 8.4.2. Laboratory-based Tests
    • 8.4.3. Imaging & Advanced Diagnostics
    • 8.4.4. Digital Monitoring Tools
  • 8.5. Nutritional Products
    • 8.5.1. Mineral Supplements
    • 8.5.2. Vitamin Supplements
    • 8.5.3. Probiotics & Prebiotics
    • 8.5.4. Electrolytes & Rehydration Products
    • 8.5.5. Specialized Therapeutic Diets
  • 8.6. Feed Additives
    • 8.6.1. Performance-enhancing Additives
    • 8.6.2. Mycotoxin Binders
    • 8.6.3. Enzyme Additives
    • 8.6.4. Acidifiers & Buffers
  • 8.7. Monitoring Devices & Wearables
    • 8.7.1. Collars & Neck Tags
    • 8.7.2. Ear Tags & Implants
    • 8.7.3. Rumination & Ingestion Sensors
    • 8.7.4. Activity & Locomotion Sensors
    • 8.7.5. Health Event Alert Systems
  • 8.8. Farm Management Software & Services
    • 8.8.1. Health Record Management
    • 8.8.2. Decision Support & Analytics
    • 8.8.3. Telemedicine & Remote Monitoring Platforms
    • 8.8.4. Integration & Data Services

9. Cattle Health Market, by Cattle Type

  • 9.1. Dairy Cattle
  • 9.2. Beef Cattle
  • 9.3. Dual-purpose Cattle
  • 9.4. Calves
  • 9.5. Bulls & Breeding Stock

10. Cattle Health Market, by Mode Of Administration

  • 10.1. Oral
    • 10.1.1. Boluses & Tablets
    • 10.1.2. Drenches
    • 10.1.3. Pastes & Gels
    • 10.1.4. Medicated Feeds
  • 10.2. Injectable
    • 10.2.1. Subcutaneous Injections
    • 10.2.2. Intramuscular Injections
    • 10.2.3. Intravenous Injections
  • 10.3. Topical
    • 10.3.1. Pour-ons & Spot-ons
    • 10.3.2. Sprays & Dips
    • 10.3.3. Ointments & Creams
  • 10.4. Intramammary
    • 10.4.1. Lactating Cow Intramammary
    • 10.4.2. Dry Cow Intramammary
  • 10.5. Intranasal
  • 10.6. Implantable
    • 10.6.1. Growth & Hormonal Implants
    • 10.6.2. Long-acting Drug Implants
  • 10.7. Feed-based
  • 10.8. Water-based

11. Cattle Health Market, by Disease Area

  • 11.1. Infectious Diseases
    • 11.1.1. Bacterial Infections
    • 11.1.2. Viral Infections
    • 11.1.3. Fungal Infections
    • 11.1.4. Mixed & Opportunistic Infections
  • 11.2. Parasitic Diseases
    • 11.2.1. Internal Parasites
    • 11.2.2. External Parasites
    • 11.2.3. Protozoal Infections
  • 11.3. Mastitis & Udder Health
  • 11.4. Respiratory Diseases
    • 11.4.1. Upper Respiratory Diseases
    • 11.4.2. Lower Respiratory Diseases
    • 11.4.3. Complex Respiratory Syndromes
  • 11.5. Gastrointestinal Diseases
    • 11.5.1. Diarrheal Diseases
    • 11.5.2. Bloat & Acidosis
  • 11.6. Metabolic & Nutritional Disorders
    • 11.6.1. Energy Metabolism Disorders
    • 11.6.2. Mineral Imbalances
    • 11.6.3. Vitamin Deficiencies
    • 11.6.4. Rumen Function Disorders
  • 11.7. Reproductive & Obstetric Disorders
    • 11.7.1. Fertility Management Issues
    • 11.7.2. Peripartum & Postpartum Disorders
    • 11.7.3. Venereal Diseases
  • 11.8. Lameness & Musculoskeletal Disorders
    • 11.8.1. Hoof & Claw Disorders
    • 11.8.2. Joint & Limb Disorders
    • 11.8.3. Trauma & Injury

12. Cattle Health Market, by End User

  • 12.1. Large Commercial Farms
  • 12.2. Small & Medium Farms
  • 12.3. Veterinary Hospitals & Clinics
  • 12.4. Mobile & Ambulatory Veterinary Services
  • 12.5. Livestock Cooperatives & Producer Groups
  • 12.6. Government & Academic Institutions
  • 12.7. Animal Health Service Providers
    • 12.7.1. Reproductive Management Service Providers
    • 12.7.2. Herd Health Consulting Firms
    • 12.7.3. Extension & Advisory Services

13. Cattle Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cattle Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cattle Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cattle Health Market

17. China Cattle Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Biomin GmbH
  • 18.6. Boehringer Ingelheim International GmbH
  • 18.7. Ceva Sante Animale SA
  • 18.8. Dechra Pharmaceuticals PLC
  • 18.9. Elanco Animal Health Incorporated
  • 18.10. Hester Biosciences Limited
  • 18.11. Huvepharma AD
  • 18.12. IDEXX Laboratories, Inc.
  • 18.13. Indian Immunologicals Limited
  • 18.14. Intas Pharmaceuticals Ltd.
  • 18.15. Jurox Pty Ltd.
  • 18.16. Kemin Industries, Inc.
  • 18.17. Laboratorios Hipra, S.A.
  • 18.18. Meiji Seika Pharma Co., Ltd.
  • 18.19. Merck & Co., Inc.
  • 18.20. Neogen Corporation
  • 18.21. Norbrook Laboratories Ltd.
  • 18.22. Ouro Fino Saude Animal Ltda.
  • 18.23. Phibro Animal Health Corporation
  • 18.24. Phytobiotics Futterzusatzstoffe GmbH
  • 18.25. Vaxxinova International B.V.
  • 18.26. Vetoquinol SA
  • 18.27. Virbac SA
  • 18.28. Zoetis Inc.
  • 18.29. Zydus Animal Health and Investments Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATTLE HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CATTLE HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY & ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY & ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY & ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & REPRODUCTIVE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & REPRODUCTIVE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & REPRODUCTIVE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE HEALTH MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE HEALTH MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CATTLE HEALTH MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATTLE HEALTH MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY INACTIVATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATTLE HEALTH MARKET SIZE, BY INACTIVATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOXOID VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOXOID VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATTLE HEALTH MARKET SIZE, BY RECOMBINANT & SUBUNIT VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CATTLE HEALTH MARKET SIZE, BY RECOMBINANT & SUBUNIT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATTLE HEALTH MARKET SIZE, BY RECOMBINANT & SUBUNIT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMBINATION VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMBINATION VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATTLE HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATTLE HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATTLE HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID ON-FARM TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID ON-FARM TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID ON-FARM TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY-BASED TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY-BASED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMAGING & ADVANCED DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMAGING & ADVANCED DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMAGING & ADVANCED DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIGITAL MONITORING TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIGITAL MONITORING TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIGITAL MONITORING TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CATTLE HEALTH MARKET SIZE, BY ELECTROLYTES & REHYDRATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CATTLE HEALTH MARKET SIZE, BY ELECTROLYTES & REHYDRATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CATTLE HEALTH MARKET SIZE, BY ELECTROLYTES & REHYDRATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPECIALIZED THERAPEUTIC DIETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPECIALIZED THERAPEUTIC DIETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPECIALIZED THERAPEUTIC DIETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERFORMANCE-ENHANCING ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERFORMANCE-ENHANCING ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERFORMANCE-ENHANCING ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CATTLE HEALTH MARKET SIZE, BY MYCOTOXIN BINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATTLE HEALTH MARKET SIZE, BY MYCOTOXIN BINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CATTLE HEALTH MARKET SIZE, BY MYCOTOXIN BINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYME ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYME ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYME ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACIDIFIERS & BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACIDIFIERS & BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACIDIFIERS & BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATTLE HEALTH MARKET SIZE, BY COLLARS & NECK TAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CATTLE HEALTH MARKET SIZE, BY COLLARS & NECK TAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATTLE HEALTH MARKET SIZE, BY COLLARS & NECK TAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CATTLE HEALTH MARKET SIZE, BY EAR TAGS & IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CATTLE HEALTH MARKET SIZE, BY EAR TAGS & IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CATTLE HEALTH MARKET SIZE, BY EAR TAGS & IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMINATION & INGESTION SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMINATION & INGESTION SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMINATION & INGESTION SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACTIVITY & LOCOMOTION SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACTIVITY & LOCOMOTION SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACTIVITY & LOCOMOTION SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH EVENT ALERT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH EVENT ALERT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH EVENT ALERT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH RECORD MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH RECORD MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH RECORD MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CATTLE HEALTH MARKET SIZE, BY DECISION SUPPORT & ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CATTLE HEALTH MARKET SIZE, BY DECISION SUPPORT & ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CATTLE HEALTH MARKET SIZE, BY DECISION SUPPORT & ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CATTLE HEALTH MARKET SIZE, BY TELEMEDICINE & REMOTE MONITORING PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CATTLE HEALTH MARKET SIZE, BY TELEMEDICINE & REMOTE MONITORING PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CATTLE HEALTH MARKET SIZE, BY TELEMEDICINE & REMOTE MONITORING PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTEGRATION & DATA SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTEGRATION & DATA SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTEGRATION & DATA SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CATTLE HEALTH MARKET SIZE, BY DUAL-PURPOSE CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CATTLE HEALTH MARKET SIZE, BY DUAL-PURPOSE CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CATTLE HEALTH MARKET SIZE, BY DUAL-PURPOSE CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CATTLE HEALTH MARKET SIZE, BY BULLS & BREEDING STOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CATTLE HEALTH MARKET SIZE, BY BULLS & BREEDING STOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL CATTLE HEALTH MARKET SIZE, BY BULLS & BREEDING STOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CATTLE HEALTH MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CATTLE HEALTH MARKET SIZE, BY BOLUSES & TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL CATTLE HEALTH MARKET SIZE, BY BOLUSES & TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CATTLE HEALTH MARKET SIZE, BY BOLUSES & TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRENCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRENCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRENCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL CATTLE HEALTH MARKET SIZE, BY PASTES & GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL CATTLE HEALTH MARKET SIZE, BY PASTES & GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL CATTLE HEALTH MARKET SIZE, BY PASTES & GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CATTLE HEALTH MARKET SIZE, BY MEDICATED FEEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CATTLE HEALTH MARKET SIZE, BY MEDICATED FEEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CATTLE HEALTH MARKET SIZE, BY MEDICATED FEEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL CATTLE HEALTH MARKET SIZE, BY SUBCUTANEOUS INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL CATTLE HEALTH MARKET SIZE, BY SUBCUTANEOUS INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL CATTLE HEALTH MARKET SIZE, BY SUBCUTANEOUS INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMUSCULAR INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMUSCULAR INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMUSCULAR INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL CATTLE HEALTH MARKET SIZE, BY POUR-ONS & SPOT-ONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL CATTLE HEALTH MARKET SIZE, BY POUR-ONS & SPOT-ONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL CATTLE HEALTH MARKET SIZE, BY POUR-ONS & SPOT-ONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPRAYS & DIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPRAYS & DIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPRAYS & DIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL CATTLE HEALTH MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL CATTLE HEALTH MARKET SIZE, BY OINTMENTS & CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL CATTLE HEALTH MARKET SIZE, BY OINTMENTS & CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL CATTLE HEALTH MARKET SIZE, BY LACTATING COW INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL CATTLE HEALTH MARKET SIZE, BY LACTATING COW INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL CATTLE HEALTH MARKET SIZE, BY LACTATING COW INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRY COW INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRY COW INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRY COW INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRANASAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRANASAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH & HORMONAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH & HORMONAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH & HORMONAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL CATTLE HEALTH MARKET SIZE, BY LONG-ACTING DRUG IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL CATTLE HEALTH MARKET SIZE, BY LONG-ACTING DRUG IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL CATTLE HEALTH MARKET SIZE, BY LONG-ACTING DRUG IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL CATTLE HEALTH MARKET SIZE, BY WATER-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL CATTLE HEALTH MARKET SIZE, BY WATER-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL CATTLE HEALTH MARKET SIZE, BY WATER-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL CATTLE HEALTH MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL CATTLE HEALTH MARKET SIZE, BY FUNGAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL CATTLE HEALTH MARKET SIZE, BY FUNGAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL CATTLE HEALTH MARKET SIZE, BY MIXED & OPPORTUNISTIC INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL CATTLE HEALTH MARKET SIZE, BY MIXED & OPPORTUNISTIC INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL CATTLE HEALTH MARKET SIZE, BY MIXED & OPPORTUNISTIC INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTERNAL PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTERNAL PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTERNAL PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL CATTLE HEALTH MARKET SIZE, BY EXTERNAL PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL CATTLE HEALTH MARKET SIZE, BY EXTERNAL PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL CATTLE HEALTH MARKET SIZE, BY EXTERNAL PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROTOZOAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROTOZOAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROTOZOAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL CATTLE HEALTH MARKET SIZE, BY MASTITIS & UDDER HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL CATTLE HEALTH MARKET SIZE, BY MASTITIS & UDDER HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL CATTLE HEALTH MARKET SIZE, BY MASTITIS & UDDER HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL CATTLE HEALTH MARKET SIZE, BY UPPER RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL CATTLE HEALTH MARKET SIZE, BY UPPER RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL CATTLE HEALTH MARKET SIZE, BY UPPER RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL CATTLE HEALTH MARKET SIZE, BY LOWER RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL CATTLE HEALTH MARKET SIZE, BY LOWER RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL CATTLE HEALTH MARKET SIZE, BY LOWER RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMPLEX RESPIRATORY SYNDROMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMPLEX RESPIRATORY SYNDROMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMPLEX RESPIRATORY SYNDROMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIARRHEAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIARRHEAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIARRHEAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL CATTLE HEALTH MARKET SIZE, BY BLOAT & ACIDOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL CATTLE HEALTH MARKET SIZE, BY BLOAT & ACIDOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL CATTLE HEALTH MARKET SIZE, BY BLOAT & ACIDOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENERGY METABOLISM DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENERGY METABOLISM DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENERGY METABOLISM DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL IMBALANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 292. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL IMBALANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL IMBALANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN DEFICIENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 295. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN DEFICIENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN DEFICIENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMEN FUNCTION DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 298. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMEN FUNCTION DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMEN FUNCTION DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 301. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 304. GLOBAL CATTLE HEALTH MARKET SIZE, BY FERTILITY MANAGEMENT ISSUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 305. GLOBAL CATTLE HEALTH MARKET SIZE, BY FERTILITY MANAGEMENT ISSUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL CATTLE HEALTH MARKET SIZE, BY FERTILITY MANAGEMENT ISSUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERIPARTUM & POSTPARTUM DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 308. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERIPARTUM & POSTPARTUM DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERIPARTUM & POSTPARTUM DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. GLOBAL CATTLE HEALTH MARKET SIZE, BY VENEREAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 311. GLOBAL CATTLE HEALTH MARKET SIZE, BY VENEREAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL CATTLE HEALTH MARKET SIZE, BY VENEREAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. GLOBAL CATTLE HEALTH MARKET SIZE, BY LAMENESS & MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 314. GLOBAL CATTLE HEALTH MARKET SIZE, BY LAMENESS & MUSCULOSKELETAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL CATTLE HEALTH MARKET SIZE, BY LAM